Document dxZKy0q2JD3vrqrqggEYB21Q

11572-1000 MXY/dal persons attending, and any and all documents referring to, relating to or reflecting the meeting; (c) Ifknowledge was obtained from medical or scientific studies, or work, published or unpublished, identify the same. . ANSWER: See Answer to Interrogatory No. 81, which is incorporated herein as if fully rewritten. . INTERROGATORY NO. 83: With regard to any knowledge or information obtained subsequent to that identified in your Answer to Interrogatory No. 82 (a), identify any and all documents or communications (oral and/or written) concerning the causal connection between exposure to asbestos-containing or asbestos products and any disease, which were sent to, or received by, Defendant, and identify any and all persons conveying and/or receiving such communications. ANSWER: See Answer to Interrogatory No. 79, which is incorporated herein as if fully rewritten. INTERROGATORY NO. 84: As to any knowledge or information referred to in Interrogatories 79-83, did Defendant, at any time, educate or inform its employees, distributors, purchasers or any persons working in the vicinity where any asbestos-containing product was being applied or installed as to the hazards known to Defendant or about which Defendant had information, and as to the safety precautions necessary to guard against cancer and other diseases arising from the use and handling of the products identified in response to Interrogatory No. 19? ANSWER: 92